0001213900-24-014412.txt : 20240215
0001213900-24-014412.hdr.sgml : 20240215
20240215122641
ACCESSION NUMBER: 0001213900-24-014412
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240215
DATE AS OF CHANGE: 20240215
EFFECTIVENESS DATE: 20240215
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medical Realities, Inc.
CENTRAL INDEX KEY: 0001998240
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
ORGANIZATION NAME: 06 Technology
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 0831
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-505379
FILM NUMBER: 24642950
BUSINESS ADDRESS:
STREET 1: 71-75 SHELTON STREET, COVENT GARDEN
CITY: LONDON
STATE: X0
ZIP: WC2H 9JQ
BUSINESS PHONE: 44 2080926261
MAIL ADDRESS:
STREET 1: 71-75 SHELTON STREET, COVENT GARDEN
CITY: LONDON
STATE: X0
ZIP: WC2H 9JQ
D
1
primary_doc.xml
X0708
D
LIVE
0001998240
Medical Realities, Inc.
25 CABOT SQUARE
LONDON
X0
UNITED KINGDOM
E14 4QZ
+44 2080926261
CAYMAN ISLANDS
None
None
Corporation
true
2023
Shafi
Ahmed
c/o Medical Realities, Inc.
25 CABOT SQUARE
LONDON
X0
UNITED KINGDOM
E14 4QZ
Executive Officer
Chief Executive Officer
Stephen
Dann
c/o Medical Realities, Inc.
25 CABOT SQUARE
LONDON
X0
UNITED KINGDOM
E14 4QZ
Executive Officer
Director
Executive Chairman
Keith
Charles
Moore
c/o Medical Realities, Inc.
25 CABOT SQUARE
LONDON
X0
UNITED KINGDOM
E14 4QZ
Director
Holds (a) voting pwr over Co.'s shares held by Latigo Ptnrs, which holds 20% of Co.'s shares & 31.3% of voting pwr of shares (b) 49% of voting pwr of common of Boustead & Company Ltd., which holds 20% of Co.'s shares & 31.3% of voting pwr of shares.
Other Technology
Decline to Disclose
- 06b
false
2023-08-14
false
true
false
25000
Boustead Securities, LLC
141391
None
None
6 VENTURE
SUITE 395
IRVINE
CA
CALIFORNIA
92618
TX
TEXAS
true
1000000
475000
525000
false
3
33250
0
Boustead Securities, LLC also received non-accountable expense allowance of $4,750, will receive 5-yr warrant to purchase 33,250 Class B Ordinary Shares, exercisable on a cashless basis, at exercise price of $1.00 per share, subject to adjustment.
0
false
Medical Realities, Inc.
/s/ Shafi Ahmed
Shafi Ahmed
Chief Executive Officer
2024-02-15